RPL9P15

Across TCGA pan-cancer cohorts, RPL9P15 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RPL9P15 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RPL9P15 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL9P15 expression acts as an unfavorable survival marker, although some lineages such as KIRC and STAD show a favorable association.

HNSC, UCS, and ACC are the cancer types where RPL9P15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.502	0.703	.013	51	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
ACC	OS	Tertile	All	0.147	0.685	.018	18	view →
LIHC	DFS	Tertile	III,IV	0.103	0.363	.030	18	view →
KIRC	DFS	Tertile	All	0.972	0.865	.015	9	view →
STAD	DFS	Quartile	IV	0.805	0.210	.036	6	view →
SKCM	OS	Tertile	II,III,IV	0.101	0.360	.024	6	view →
COAD	OS	Tertile	All	0.210	0.675	.041	6	view →
LGG	DFS	Tertile	All	0.180	0.457	.042	6	view →
LAML	DFS	Tertile	All	0.475	0.623	.035	2	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RPL9P15–HNSC (DFS)

Open the HNSC breakdown →